MADISON BECKLEY: Open Payments
NPI 1780341826 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,869 in 77 payments from 16 companies in 2025. Trend: 2023 $1,783 · 2024 $1,924 · 2025 $1,869
Food & beverage: $1,869
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 12 | $459 |
| Amgen Inc. | 12 | $278 |
| Alexion Pharmaceuticals, Inc. | 7 | $190 |
| Otsuka America Pharmaceutical, Inc. | 9 | $160 |
| Vifor Pharma, Inc. | 4 | $117 |
| Ardelyx, Inc. | 6 | $117 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $115 |
| AstraZeneca Pharmaceuticals LP | 7 | $110 |
| Calliditas Therapeutics US Inc. | 4 | $109 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
Products named: TAVNEOS, ULTOMIRIS, Filspari, Veltassa, IBSRELA, JYNARQUE, Kerendia, FARXIGA.
Industry payments across KY — which companies pay providers there.
